Oral inhibition of interleukin-1 in the treatment of osteoarthritis.
DIACEREIN is indicated for the specific, long-term oral treatment of degenerative joint diseases (osteoarthritis and related diseases). DIACEREIN has a unique mode of action through inhibition of the production and activity of interleukin-1, the key mediator in the progression of osteoarthritis.
DIACEREIN is effective in reducing pain and functional impairment, the major symptoms of OA, and has shown structure-modifying effects with good gastrointestinal tolerability.
Product category
Orthopedics
Brunac Eye Drop contains N-Acetyl Cysteine. The molecule is a corneal collagenase enzyme inhibitor. It is indicated for corneal ulcers, keratitis of different etiologies, and corneal diseases arising from lacrimal secretion changes.
Sterile Solution contains methoxsalen and is indicated for extracorporeal administration with Therakos CELLEX® Photopheresis System in the palliative treatment of the skin manifestations of Cutaneous T-Cell Lymphoma (CTCL) that is unresponsive to other forms of treatment.
Brumeton Eye Drop contains Betamethasone and Sodium sulfacetamide. It is indicated for the topical treatment and prophylaxis of non-purulent chronic and acute allergic blepharitis and blepharo conjunctivitis (seborral, allergic, staphylococcal).